J. F. Amador

Monoclonal anti-EGFreceptor antibody (ior-R3) pharmacokinetic study in tumor bearing nude mice: Role of the receptor-mediated endocytosis on drug clearance

J. Duconge, E. Fernández-Sánchez, A. Macias, 2002, European Journal of Drug Metabolism and Pharmacokinetics.

Tumor-specific immunotherapy based on dominant models of natural tolerance.

E. Montero, A. Lage, R. Pérez, 2000, Medical hypotheses.

Toxic effects of interleukin-2-activated lymphocytes on vascular endothelial cells.

A. Barral, R. Gendelman, M. Jondal, 1991, Natural immunity and cell growth regulation.

CD6 molecule may be important in the pathological mechanisms of lymphocytes adhesion to human skin in psoriasis and ior t1 MAb a possible new approach to treat this disease.

E. Montero, J. Delgado, J. F. Amador, 1999, Autoimmunity.

Low IL-1 beta production in leukemic cells from progressive B cell chronic leukemia (B-CLL).

H. Mellstedt, M. Jondal, M. Aguilar-Santelises, 1989, Leukemia research.

Agricultural business models: a Mexican case

A. Vera-Cruz, J. F. Amador, 2013 .

Biopharmaceuticals in Latin America: challenges and opportunities

J. Niosi, J. F. Amador, T. G. Bas, 2013 .

Linking HEIs with the production sector: A communication approach between key actors in Ciudad Juárez, Mexico

Carmen Reaiche, J. F. Amador, Tomás Francisco Limones Meráz, 2020 .